Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Bragg Treatment in Advanced Refractory NSCLC
NCT06047860Phase 2Unknown
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Jun 2023
- Primary completion
- Dec 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by The Second Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT06047860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06047860.